Sweden· SE-19831111000027
Cyclopentolat Bausch & Lomb 1 % (10 mg/ml) Ögondroppar, lösning i endosbehållare
A cyclopentolate product containing cyclopentolate hydrochloride, registered in Sweden by Bausch & Lomb Ireland Limited. The same ATC class is registered in 16 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Cyclopentolate is registered in 16 of 19 countries.
Countries holding a registration under ATC S01FA04 (cyclopentolate), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 8 of them publish a price we can compare per daily dose
Cyclopentolate · ATC S01FA04
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Cyclopentolate Hydrochloride
- Manufacturer
- Bausch & Lomb Ireland Limited
- Country
- Sweden (SE)
- ATC code
- S01FA04
- ATC class
- Cyclopentolate
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19831111000027
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for cyclopentolate.
Graded by severity as the source publishes them — 3 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cyclopentolate · interactions on record
3 records
- 3 moderate
Most severe, free to view
- PhenylephrineC01CA06moderate
- PhysostigmineS01EB05moderate
- PhysostigmineV03AB19moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cyclopentolate in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandMinims Cyclopentolate HydrochlorideChauvin Pharmaceuticals Limited
- CzechiaCYCLOPENTOLATE OLIKLAOlikla s.r.o., Kostelec nad Černými Lesy
- United StatesCyclogylAlcon Laboratories, Inc.
- PolandCykloftyalVerco S.A.
- NetherlandsMinims Cyclopentolaathydrochloride 10 mg/ml, oogdruppels, oplossingBausch + Lomb Ireland Limited
- IcelandCyclogylAlcon Nordic A/S
- NorwayCyclopentolat MinimsBAUSCH + LOMB IRELAND LIMITED
- United KingdomMinims cyclopentolate hydrochloride 0.5% eye drops 0.5ml unit doseBausch & Lomb UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Belgium · Cyclogyl, Minims Cyclopentolaathydrochloride Bausch + Lomb Ireland Limited
- Bulgaria · Цикловижън
- Cyprus · Cyclogyl
- Czechia · Cyclopentolate Olikla
- Germany · Cyclopentolat Alcon, Zyklolat Edo
- Denmark · Cyclogyl
- Spain · Colirofta Ciclopléjico
- Finland · Oftan Syklo
- France · Skiacol
- Greece · Cyclogyl
- Hungary · Humapent
- Ireland · Minims
- Iceland · Cyclogyl
- Italy · Ciclolux, Plegik
- Lithuania · Cyclogyl
- Luxembourg · Minims, Minims Cyclopentolate Chlorhydrate Bausch + Lomb Ireland Limited
- Malta · Minims Cyclopentolate Hydrochloride Bausch + Lomb Ireland
- Netherlands · Cyclogyl, Minims Cyclopentolaathydrochloride Bausch + Lomb Ireland Limited
- Norway · Cyclopentolat Bausch + Lomb Ireland Limited
- Poland · Cykloftyal
- Portugal · Cicloplegicedol, Midriodavi
- Slovakia · Cyclopentolate Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3a22745-39a1-4f4b-a5e5-0fa126525750 GET /v1/drugs/b3a22745-39a1-4f4b-a5e5-0fa126525750?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "19831111000027",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19831111000027",
"product_doc_link": "https://docetp.mpa.se/LMF/Cyclopentolat%20%20Bausch%20%26%20Lomb%20eye%20drops%2C%20solution%20single-dose%20container%20SmPC_09001bee807a40dc.pdf"
}See everything about cyclopentolate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.